MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

Topline data were announced from the phase 3 INDIGO trial evaluating obexelimab in adults with immunoglobulin G4-related disease.

Consolidating treatment to a single bispecific antibody for DLBCL and follicular lymphoma can improve operational efficiency ...